Listar Technical documents and research evidence on COVID-19 por título
Mostrando ítems 464-483 de 1749
-
Detection of Zika virus RNA in whole blood of imported Zika virus disease cases up to 2 months after symptom onset, Israel, December 2015 to April 2016
(2016-06)Zika virus RNA presence in serum, whole-blood and urine samples from six Israeli travellers symptomatic for Zika virus disease was examined. Whole-blood samples were positive for as late as 2 months (58 days) post-symptom ... -
Developing Covid-19 Vaccines at Pandemic Speed
(2020-03-30)The need to rapidly develop a vaccine against SARS-CoV-2 comes at a time of explosion in basic scientific understanding, including in areas such as genomics and structural biology, that is supporting a new era in vaccine ... -
Development and Multicenter Performance Evaluation of The First Fully Automated SARS-CoV-2 IgM and IgG Immunoassays
(2020-04-21)BACKGROUND: The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread globally. The laboratory diagnosis of SARS-CoV-2 infection has relied on nucleic acid tests. However, there are ... -
Development and validation of an early warning score (EWAS) for predicting clinical deterioration in patients with coronavirus disease 2019
(2020-04-21)Background: Since the pandemic outbreak of coronavirus disease 2019 (COVID-19), the health system capacity in highly endemic areas has been overwhelmed. Approaches to efficient management are urgently needed. We aimed to ... -
Development of Genetic Diagnostic Methods for Novel Coronavirus 2019 (nCoV-2019) in Japan
(2020-02-13)At the end of 2019, pneumonia caused by novel coronavirus 2019 (nCoV) emerged in Wuhan city, China. Many airline travelers moved between Wuhan and Japan at that time, suggesting that Japan is at high risk of invasion by ... -
Diabetes and COVID-19 (multiple reviews)
(2021-01-04)What is this? If a patient has comorbidities, such as diabetes, this may affect their risk of contracting COVID-19 and the severity of their disease. Several rapid reviews are summarised here. For more details including ... -
Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19
(2020-06-08)Coronavirus disease 2019 (COVID‐19), a respiratory tract infection caused by a novel human coronavirus, the severe acute respiratory syndrome coronavirus 2, leads to a wide spectrum of clinical manifestations ranging from ... -
Diagnosis, management and follow-up of pregnant women with Zika virus infection: A preliminary report of the ZIKERNCOL cohort study on Sincelejo, Colombia
(2016-06)Zika virus infection (ZIKV) has emerged as a significant threat for the health of pregnant women and newborns in populations living or visiting Latin America since the epidemic begun in 2015 [1], [2]. Reported possible ... -
A diagnostic polymerase chain reaction assay for Zika virus
(2014)Zika virus (ZIKV) is a mosquito-borne flavivirus. Infection results in a dengue-like illness with fever, headache, malaise, and a maculopapular rash. Nearly all cases are mild and self-limiting but in 2007, a large outbreak ... -
Diagnostic power of chest CT for COVID-19: to screen or not to screen
(2020-05-24)Background: chest CT is increasingly used for COVID-19 screening in healthcare systems with limited SARS-CoV-2 PCR capacity. Its diagnostic value was supported by studies with methodological concerns and its use is ... -
Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus-2: A Narrative Review
(2020-04-13)Diagnostic testing to identify persons infected with severe acute respiratory syndrome–related coronavirus-2 (SARS–CoV-2) infection is central to control the global pandemic of COVID-19 that began in late 2019. In a few ... -
Differential Susceptibilities of Aedes aegypti and Aedes albopictus from the Americas to Zika Virus
(2016-06)Since the major outbreak in 2007 in the Yap Island, Zika virus (ZIKV) causing dengue-like syndromes has affected multiple islands of the South Pacific region. In May 2015, the virus was detected in Brazil and then spread ... -
Differential ventilation using flow control valves as a potential bridge to full ventilatory support during the COVID-19 crisis
(2020-04-21)Background: It has been projected that there will be too few ventilators to meet demand during the COVID-19 (SARS CoV-2) pandemic. Ventilator sharing has been suggested as a crisis standard of care strategy to increase ... -
Digital health and the COVID-19 epidemic: an assessment framework for apps from an epidemiological and legal perspective
(2020-05-17)As COVID-19 spreads across the globe, crowdsourced digital technology harbours the potential to improve surveillance and epidemic control, primarily through increased information coverage, higher information speed, fast ... -
The dilemma of COVID-19 in dental practice concerning the role of saliva in transmission: a brief review of current evidence
(2020-05)From December 12, 2019, a pandemic of acute respiratory syndrome, the novel human coronavirus disease (COVID-19), caused by a novel β-coronavirus (2019-nCoV) began to grow globally by person-to-person transmission. The ... -
Directly Acting Antivirals for COVID-19: Where Do We Stand?
(2020-08-05)The outbreak of a novel coronavirus (SARS-CoV-2) in Wuhan, China in December 2019 has now become a pandemic with no approved therapeutic agent. At the moment, the genomic structure, characteristics, and pathogenic mechanisms ... -
Disability considerations during the COVID-19 outbreak
(2020-03-26)Considerations for actors: Actions for people with disability and their household Reduce your potential exposure to COVID-19. Everyone with disability and their household should follow the WHO guidance on basic protection ... -
Discovering Drugs to Treat Coronavirus Disease 2019 (COVID-19)
The SARS-CoV-2 virus emerged in December 2019 and then spread rapidly worldwide, particularly to China, Japan, and South Korea. Scientists are endeavoring to find antivirals specific to the virus. Several drugs such as ...